Previous
 

Personen er ikke tilknyttet DTU


Continue to the research database for further information
Research output
News
LoadingText

News from DTU

2020
16 APR

Psychedelic compound from magic mushrooms produced in yeast

Scientists from DTU Biosustain prove that psilocybin, a potential drug for treating depression and other psychological conditions can be produced in yeast.

Biotechnology and biochemistry
2019
Photo: Octarine
19 AUG

Biotech start-up targets billion-dollar market by producing superior cannabinoids in yeast

The young biotech start-up Octarine Bio seeks to commercialize the production of brand-new tailored cannabinoids in yeast. Around one thousand new molecules have already been identified, but the company will focus on those with the highest commercial potential.

Photo: Anders Østerby Mønsted
19 AUG

Start-up to challenge big guns with artificial cannabis substances

With its tailored cannabis substances, the biotech start-up Octarine Bio is eyeing the growing market for pain relieving drugs.

Biotechnology and biochemistry Medicine and medico technology
20 JUN

Biotech start-up targets billion-dollar market by producing superior cannabinoids in yeast

The young biotech start-up Octarine Bio seeks to commercialize the production of brand-new tailored cannabinoids in yeast. Around one thousand new molecules have already been identified, but the company will focus on those with the highest commercial potential.